Martingale Asset Management »

Blueprint Medicines shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.6M 15k 107.78
2024-03-31 $1.3M 14k 94.86
2023-12-31 $1.3M 14k 92.24
2023-09-30 $809k 16k 50.22
2023-06-30 $1.0M 16k 63.20
2023-03-31 $748k 17k 44.99
2021-12-31 $1.7M 16k 107.16
2021-09-30 $2.8M 27k 102.82
2021-06-30 $1.3M 14k 88.00
2021-03-31 $449k 4.6k 97.41
2020-12-31 $394k 3.5k 112.35
2020-09-30 $844k 9.1k 92.72
2020-06-30 $820k 11k 78.07